Pharvaris N.V.

Pharvaris N.V.

29.85
EUR
0.00
(0.00%)
-2.69EPS
1.98BMarket Cap
Apr 08Next Earn

Total Valuation

EUR

As of September 30, 2026, Pharvaris N.V. carries a market capitalization of 1.98B, placing it among publicly traded companies globally. Its enterprise value stands at 1.70B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.98B
Enterprise Value1.70B

Important Dates

Pharvaris N.V.'s next confirmed earnings release is scheduled for April 8, 2027.

Earnings Date4/8/2027

Share Statistics

As of September 30, 2026, Pharvaris N.V. has 70.79M shares outstanding.

Shares Outstanding70.79M

Valuation Ratios

These figures are as of September 30, 2026.

PB Ratio7.48
P/TBV Ratio7.48
P/FCF Ratio-11.29
P/OCF Ratio-11.29

Financial Position

As of September 30, 2026, Pharvaris N.V. maintains a current ratio of 9.89, meaning it holds 9.9x the short-term assets needed to cover near-term liabilities.

Current Ratio9.89
Quick Ratio9.73
Debt / Equity0.23

Financial Efficiency

Over the twelve months ended September 30, 2026, Pharvaris N.V. posted a negative return on equity (ROE) of -62.78, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -57.16, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 129.00, a quick read on workforce productivity versus industry peers.

Return on Equity (ROE)-62.78
Return on Assets (ROA)-57.16
Employee Count129.00

Taxes

EUR

Over the twelve months ended September 30, 2026, Pharvaris N.V. recorded 2.75M in income tax expense. The company reported a pretax loss of -178.44M and -181.20M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax2.75M

Stock Price Statistics

EUR

As of the close on November 17, 2026, Pharvaris N.V.'s stock has gained approximately 39.49% over the past 52 weeks. The 50-day moving average sits at 29.40, while the 200-day moving average is 27.36.

52-Week Price Change39.49%
50-Day Moving Average29.40
200-Day Moving Average27.36

Income Statement

EUR

Over the twelve months ended September 30, 2026, Pharvaris N.V. generated - - in revenue and converted that into -181.20M in net income, yielding earnings per share of -2.69. EBITDA reached -192.26M, while operating income came in at -192.74M.

Operating Income-192.74M
Pretax Income-178.44M
Net Income-181.20M
EBITDA-192.26M
EBIT-192.74M
Earnings Per Share (EPS)-2.69

Balance Sheet

EUR

As of September 30, 2026, Pharvaris N.V. holds 282.73M in cash and equivalents against 603,935.00 in total debt, resulting in a net debt position of -282.73M. Total book value stands at 264.97M, with working capital of 263.55M providing operational flexibility.

Cash & Cash Equivalents282.73M
Total Debt603,935.00
Net Debt-282.73M
Equity (Book Value)264.97M
Book Value Per Share3.74
Working Capital263.55M

Cash Flow

EUR

Pharvaris N.V. produced -166.74M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -80,542.00 in capital expenditures, free cash flow totaled -166.82M - equivalent to -2.48 per share.

Operating Cash Flow-166.74M
Capital Expenditures-80,542.00
Free Cash Flow-166.82M
FCF Per Share-2.48

Dividends & Yields

These figures cover the twelve months ended September 30, 2026. Free cash flow yield is negative at -8.86: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -5.66, meaning Pharvaris N.V. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-5.66
FCF Yield-8.86

Scores

As of September 30, 2026, Pharvaris N.V. has an Altman Z-Score of 35.04, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score35.04